Dr. Tayyeba Kanwal Ali, MD

Dr. Ali practices at Palo Alto Medial Foundation in Sunnyvale, California.

Dr. Ali's NPI, 1891947925, was assigned on October 21, 2008. Dr. Ali graduated from Emory School of Medicine in 2007. Dr. Ali holds California license C150277.

Dr. Ali's primary practice is Palo Alto Medial Foundation, at 1085 W El Camino Real, Sunnyvale, CA 94087-1030. The practice phone is (408) 524-5900.

Dr. Ali's primary practice is Palo Alto Medial Foundation in Sunnyvale, California. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Ali to 2 more medical groups, 1 community health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ali practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Ali's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Ali is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Ali's licenses on file in 3 states: California, Florida and Arkansas.

Dmand AI lists cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, glaucoma, hereditary corneal conditions, inflammation of iris and scleritis among the conditions Dr. Ali treats.

CMS data shows 205 Medicare services from Dr. Ali across 4 procedure codes in 2024, for 68 Medicare patients. Medicare paid $22,058 for them. Every service was in an office.

CMS counts 68 Medicare patients who saw Dr. Ali in 2024. The largest group is 75 to 84, with 28 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ali's median patient age at 60, with 64% women.

In 2024, Dr. Ali wrote 382 Medicare Part D claims for 98 patients. 70% of them were for generic drugs. CMS names the drug for 327 of them, across 11 drugs with 11 or more claims each, at $14,816 in total drug cost. In 2023, CMS named 184 claims across 7 drugs.

Dr. Ali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Ali, published from 2008 to 2025. 2008 was the busiest year, with 2. The most frequent topics are Blotting, Western, Diabetic Retinopathy and In Situ Nick-End Labeling. Dr. Ali has published most often in Diabetologia. Dr. Ali's most frequent co-authors are Yun Liu, MD, Eduardo Alfonso, MD and Guillermo Amescua, MD.

CMS Open Payments shows 23 general payments to Dr. Ali from 7 drug and device companies from 2016 to 2021. Travel and lodging make up the largest share, 54% of the total. Valeant Pharmaceuticals International paid the most, $1,438.

Dr. Ali graduated from Emory School of Medicine in 2007.

Dr. Ali is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.